Aerpio Pharmaceuticals, Inc. logo
Aerpio Pharmaceuticals, Inc. ARPO

Aerpio Pharmaceuticals, Inc. Long-Term Debt 2011-2026 | ARPO

Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.

Main characteristics:
  • Term exceeds 12 months
  • Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
  • Repaid through regular payments (interest and/or principal) over several years
Why long-term debt is needed:
  • Investment in development
    Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital.
  • Smoothing of cash flows
    A long-term payment schedule facilitates budget planning and reduces short-term financial risks.
  • Optimization of capital structure
    A combination of equity and borrowed capital can reduce the average cost of business financing.

A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.

If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.

It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.

Examples of long-term debt:
  • Mortgage loans for property purchases
  • Corporate bonds issued by a company to raise capital
  • Project financing — long-term loans for building or expanding production facilities
  • Leasing obligations for equipment or transport

Annual Long-Term Debt Aerpio Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - 125 K 110 K 85 K 60 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
125 K 60 K 95 K

Long-Term Debt of other stocks in the Biotechnology industry

Issuer Long-Term Debt Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
273 M - 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
146 K - 2.71 % $ 14 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
167 M - -24.86 % $ 820 K usaUSA
ADMA Biologics ADMA Biologics
ADMA
69.3 M $ 15.6 -5.71 % $ 3.72 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
13.2 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
4 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
9.12 M - - $ 26.5 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
137 M $ 3.55 -2.34 % $ 1.06 B canadaCanada
I-Mab I-Mab
IMAB
68.2 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
2.42 B - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
1.83 M - -13.47 % $ 169 M franceFrance
Aptorum Group Limited Aptorum Group Limited
APM
130 K $ 0.82 -0.73 % $ 4.47 M chinaChina
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
278 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
4.76 M - -18.52 % $ 27.3 M britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
529 K - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
28.3 M - 0.23 % $ 488 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
3.38 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
16.6 M - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
93.3 M $ 20.14 1.41 % $ 2.54 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
309 M $ 75.28 -1.63 % $ 1.45 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
38 K - - $ 8.42 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
47.9 M $ 1.47 -9.81 % $ 375 M britainBritain
Aravive Aravive
ARAV
1.88 M - -13.39 % $ 1.45 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
86 M - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
175 M - - - russiaRussia
Athersys Athersys
ATHX
8.76 M - 3.77 % $ 22.4 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
755 K - 1052.0 % $ 415 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
12.7 M - - $ 521 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
118 M $ 160.48 -2.19 % $ 7.98 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
2.01 B $ 65.44 -1.65 % $ 12.5 B usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
171 K - -2.5 % $ 5.88 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
78.5 M - -4.8 % $ 255 M usaUSA
Acasti Pharma Acasti Pharma
ACST
410 K - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
962 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
25.7 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
22.7 M - -7.31 % $ 87 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
25.4 M - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
31 K - 5.93 % $ 314 M canadaCanada
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
2.74 M $ 2.75 -2.14 % $ 908 M israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
436 K $ 60.53 0.17 % $ 11.6 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
1.46 M $ 3.19 -7.14 % $ 3.73 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
2.63 M - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
12.8 M $ 2.98 -7.03 % $ 1.07 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
1.33 M - - $ 7.46 M israelIsrael
Capricor Therapeutics Capricor Therapeutics
CAPR
1.49 M $ 25.34 -0.65 % $ 679 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
5.02 M $ 34.35 -3.75 % $ 3.57 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
16 M $ 8.02 -4.75 % $ 34.7 M usaUSA